Mabpharm Limited (HK:2181) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Mabpharm Limited successfully held its Annual General Meeting (AGM) on June 21, 2024, where all proposed resolutions were unanimously passed by shareholders. Key outcomes included the re-election of executive and non-executive directors, re-appointment of Ernst & Young as auditors, and approval for the board to repurchase and issue additional shares. The total number of shares voted was 3,568,927,860, representing a 100% approval rate with no opposing votes.
For further insights into HK:2181 stock, check out TipRanks’ Stock Analysis page.